WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RPRX

Based on 3 analysts offering 12 month price targets for Royalty Pharma PLC.
Min Forecast
$48.00+43.63%
Avg Forecast
$53.33+59.58%
Max Forecast
$60.00+79.53%

Should I buy or sell RPRX stock?

Based on 3 analysts offering ratings for Royalty Pharma PLC.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RPRX stock forecasts and price targets.

RPRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 17%
84
Strong BuyMaintains$52.00+55.60%2023-05-10
Tigress Financial
Top 23%
78
BuyReiterates$60.00+79.53%2023-04-06
UBS
Bottom 7%
7
Strong BuyMaintains$48.00+43.63%2023-02-16

1 of 1

Forecast return on equity

Is RPRX forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.96%

Forecast return on assets

Is RPRX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

RPRX earnings growth forecast

How is RPRX forecast to perform vs Biotechnology companies and vs the US market?
Company
83.59%
Industry
8.26%
Market
25.64%
RPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
RPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
RPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

RPRX revenue growth forecast

How is RPRX forecast to perform vs Biotechnology companies and vs the US market?
Company
8.83%
Industry
40.04%
Market
8.42%
RPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RPRX$33.42$53.33+59.58%Strong Buy
ARGX$395.80$457.46+15.58%Strong Buy
BMRN$93.36$110.62+18.48%Buy
BGNE$227.36$308.25+35.58%Strong Buy
ALNY$193.67$253.60+30.94%Buy
View Top Biotech Stocks

Royalty Pharma Stock Forecast FAQ

Is Royalty Pharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RPRX) stock is to Strong Buy RPRX stock.

Out of 3 analysts, 2 (66.67%) are recommending RPRX as a Strong Buy, 1 (33.33%) are recommending RPRX as a Buy, 0 (0%) are recommending RPRX as a Hold, 0 (0%) are recommending RPRX as a Sell, and 0 (0%) are recommending RPRX as a Strong Sell.

If you're new to stock investing, here's how to buy Royalty Pharma stock.

What is RPRX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: RPRX) forecast ROE is N/A, which is considered weak.

What is RPRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RPRX price target, the average RPRX price target is $53.33, with the highest RPRX stock price forecast at $60.00 and the lowest RPRX stock price forecast at $48.00.

On average, Wall Street analysts predict that Royalty Pharma's share price could reach $53.33 by May 10, 2024. The average Royalty Pharma stock price prediction forecasts a potential upside of 59.58% from the current RPRX share price of $33.42.

What is RPRX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: RPRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.